Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 9430448)

Published in Neuroendocrinology on December 01, 1997

Authors

C M Cuttica1, M Giusti, L Bocca, P Sessarego, D De Martini, S Valenti, R Spaziante, G Giordano

Author Affiliations

1: DiSEM, Department of Endocrinology, Genoa, Italy.

Articles by these authors

A novel sec-independent periplasmic protein translocation pathway in Escherichia coli. EMBO J (1998) 2.57

Gender differences and aging: effects on the human heart. J Am Coll Cardiol (1995) 2.49

Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol (1999) 2.08

Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group. J Clin Endocrinol Metab (1996) 1.96

Nitrate reductase of Escherichia coli: completion of the nucleotide sequence of the nar operon and reassessment of the role of the alpha and beta subunits in iron binding and electron transfer. Mol Gen Genet (1989) 1.90

Isolation and characterization of the nikR gene encoding a nickel-responsive regulator in Escherichia coli. J Bacteriol (1999) 1.88

P0.1 is a useful parameter in setting the level of pressure support ventilation. Intensive Care Med (1995) 1.88

Tellurite reductase activity of nitrate reductase is responsible for the basal resistance of Escherichia coli to tellurite. Microbiology (1997) 1.87

TMAO anaerobic respiration in Escherichia coli: involvement of the tor operon. Mol Microbiol (1994) 1.86

A giant outburst two years before the core-collapse of a massive star. Nature (2007) 1.82

Spinal metastases with neurological manifestations. Review of 600 cases. J Neurosurg (1983) 1.76

Slowly fading super-luminous supernovae that are not pair-instability explosions. Nature (2013) 1.52

Asthma, allergy and respiratory infections: the vitamin D hypothesis. Allergy (2011) 1.50

Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum (1991) 1.50

A randomized study on eversion versus standard carotid endarterectomy: study design and preliminary results: the Everest Trial. J Vasc Surg (1998) 1.46

Retracted Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit. Br J Pharmacol (2012) 1.42

Effects of recombinant human thyrotropin on heart rate variability and blood pressure in patients on l-thyroxine-suppressive therapy for differentiated thyroid carcinoma. Horm Res (2005) 1.42

Serum leptin levels in males with delayed puberty during short-term pulsatile GnRH administration. J Endocrinol Invest (1999) 1.40

Proposed nomenclature for the genes involved in molybdenum metabolism in Escherichia coli and Salmonella typhimurium. Mol Microbiol (1992) 1.40

Acute buflomedil intoxication: a life-threatening condition. Intensive Care Med (1994) 1.39

No benefit from carotid intervention in fatal stroke prevention for >80-year-old patients. Eur J Vasc Endovasc Surg (2012) 1.39

Molecular genetic analysis of the moa operon of Escherichia coli K-12 required for molybdenum cofactor biosynthesis. Mol Microbiol (1993) 1.35

Terrestrial gamma-ray flashes as powerful particle accelerators. Phys Rev Lett (2011) 1.35

Involvement of the narJ and mob gene products in distinct steps in the biosynthesis of the molybdoenzyme nitrate reductase in Escherichia coli. Mol Microbiol (1996) 1.34

Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. Acta Anaesthesiol Scand (2011) 1.31

TorD, a cytoplasmic chaperone that interacts with the unfolded trimethylamine N-oxide reductase enzyme (TorA) in Escherichia coli. J Biol Chem (1998) 1.30

Molecular analysis of the trimethylamine N-oxide (TMAO) reductase respiratory system from a Shewanella species. J Mol Biol (1998) 1.26

Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum (1988) 1.24

Intraoperative assessment of technical perfection in carotid endarterectomy: a prospective analysis of 1305 completion procedures. Collaborators of the EVEREST study group. Eversion versus standard carotid endartectomy. Eur J Vasc Endovasc Surg (1999) 1.15

NarJ is a specific chaperone required for molybdenum cofactor assembly in nitrate reductase A of Escherichia coli. Mol Microbiol (1998) 1.14

Discovery of powerful gamma-ray flares from the Crab Nebula. Science (2011) 1.13

EPR and redox characterization of iron-sulfur centers in nitrate reductases A and Z from Escherichia coli. Evidence for a high-potential and a low-potential class and their relevance in the electron-transfer mechanism. Eur J Biochem (1992) 1.11

Mortality reduction in cardiac anesthesia and intensive care: results of the first International Consensus Conference. HSR Proc Intensive Care Cardiovasc Anesth (2011) 1.11

Expression and characterization of the Escherichia coli fdo locus and a possible physiological role for aerobic formate dehydrogenase. J Bacteriol (1995) 1.11

Treatment of trigeminal neuralgia by ophthalmic anesthetic. J Neurosurg (1992) 1.09

In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol (1992) 1.08

Sex hormone status in women suffering from rheumatoid arthritis. J Rheumatol (1986) 1.08

The inducible trimethylamine N-oxide reductase of Escherichia coli K12: its localization and inducers. Biochim Biophys Acta (1989) 1.07

The inducible trimethylamine-N-oxide reductase of Escherichia coli K12: biochemical and immunological studies. Biochim Biophys Acta (1988) 1.07

Identification and expression of the Escherichia coli fdhD and fdhE genes, which are involved in the formation of respiratory formate dehydrogenase. J Bacteriol (1990) 1.06

Presence in the 'silent' terminus region of the Escherichia coli K12 chromosome of cryptic gene(s) encoding a new nitrate reductase. Mol Microbiol (1987) 1.04

Formation of active heterologous nitrate reductases between nitrate reductases A and Z of Escherichia coli. Mol Microbiol (1992) 1.04

Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line. Cancer Res (1988) 1.04

Biochemical and immunological evidence for a second nitrate reductase in Escherichia coli K12. Eur J Biochem (1987) 1.04

The coordination and function of the redox centres of the membrane-bound nitrate reductases. Cell Mol Life Sci (2001) 1.04

Purification and further characterization of the second nitrate reductase of Escherichia coli K12. Eur J Biochem (1990) 1.03

Involvement of the narJ or narW gene product in the formation of active nitrate reductase in Escherichia coli. Mol Microbiol (1992) 1.03

Complete coordination of the four Fe-S centers of the beta subunit from Escherichia coli nitrate reductase. Physiological, biochemical, and EPR characterization of site-directed mutants lacking the highest or lowest potential [4Fe-4S] clusters. Biochemistry (1996) 1.02

Membrane reconstitution in chl-r mutants of Escherichia coli K 12. VIII. Purification and properties of the FA factor, the product of the chl B gene. Biochim Biophys Acta (1975) 1.01

Mutants of Escherichia coli specifically deficient in respiratory formate dehydrogenase activity. J Gen Microbiol (1988) 1.01

Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy (2012) 1.01

[Behavior of blood gastrin in humans after intravenous administration of cortisol]. Boll Soc Ital Biol Sper (1974) 1.00

Posterior fossa hemangioblastomas. Surg Neurol (1986) 0.98

Benign intrasellar cysts. Surg Neurol (1981) 0.98

Sudden and unexpected neonatal death: a protocol for the postmortem diagnosis of fatty acid oxidation disorders. Semin Perinatol (1999) 0.97

Identification in various chlorate-resistant mutants of a protein involved in the activation of nitrate reductase in the soluble fraction of a chlA mutant of Escherichia coli K-12. Biochim Biophys Acta (1985) 0.97

Crystal structure of oxidized trimethylamine N-oxide reductase from Shewanella massilia at 2.5 A resolution. J Mol Biol (1998) 0.97

A common pathway for the activation of several molybdoenzymes in Escherichia coli K12. Biochim Biophys Acta (1984) 0.97

Precursor forms of the subunits of nitrate reductase in chlA and chlB mutants of Escherichia coli K12. Eur J Biochem (1980) 0.97

Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors. Cancer Res (1986) 0.96

[A case of gossypiboma of the knee. Its computed tomographic diagnosis]. Radiol Med (2000) 0.96

3-Nitrotyrosine, a marker of nitrosative stress, is increased in breath condensate of allergic asthmatic children. Allergy (2006) 0.96

Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trial. J Vasc Surg (2000) 0.96

Comparison of target organ damage in renovascular and essential hypertension. Am J Hypertens (1996) 0.95

The K469E polymorphism of the ICAM-1 gene is a risk factor for peripheral arterial occlusive disease. Blood Coagul Fibrinolysis (2002) 0.95

Cost-of-illness study in acromegalic patients in Italy. J Endocrinol Invest (2004) 0.94

Requirement for phospholipids of the translocation of the trimethylamine N-oxide reductase through the Tat pathway in Escherichia coli. FEBS Lett (1999) 0.93

Serum leptin concentrations during the menstrual cycle in normal-weight women: effects of an oral triphasic estrogen-progestin medication. Eur J Endocrinol (2000) 0.93

Uterine smooth muscle tumor of uncertain malignant potential: a three-case report. Int J Gynecol Cancer (2007) 0.93

High substrate specificity and induction characteristics of trimethylamine-N-oxide reductase of Escherichia coli. Biochim Biophys Acta (1996) 0.93

Sentinel lymph node biopsy in squamous cell carcinoma of the head and neck: 10 years of experience. Acta Otorhinolaryngol Ital (2012) 0.92

Conjunctival surface damage distribution in keratoconjunctivitis sicca. An impression cytology study. Ophthalmologica (1990) 0.92

Proliferation of T8-positive cytolytic T lymphocytes in response to thyroglobulin in human autoimmune thyroiditis: analysis of cell interactions and culture requirements. Clin Immunol Immunopathol (1985) 0.92

Preliminary results of serum androgen level testing in men with rheumatoid arthritis. Arthritis Rheum (1984) 0.92

Effect of epidermal growth factor on insulin-like growth factor-I (IGF-I) and IGF-binding protein synthesis by adult rat hepatocytes. Mol Cell Endocrinol (1992) 0.92

ST/G ACL reconstruction: double strand plus extra-articular sling vs double bundle, randomized study at 3-year follow-up. Scand J Med Sci Sports (2008) 0.92

Primary cutaneous plasmacytoma: a role for a triggering stimulus? Clin Exp Dermatol (2005) 0.91

Hemangioma of the temporal muscle. Head Neck (1996) 0.91

Volume measurement with magnetic resonance imaging of hippocampus-amygdala formation in patients with anorexia nervosa. J Endocrinol Invest (2001) 0.91

Arachnoid cyst of the quadrigeminal cistern. Neurochirurgia (Stuttg) (1986) 0.90

Testosterone metabolism and cyclosporin A treatment in rheumatoid arthritis. Br J Rheumatol (1997) 0.90

Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells. Ann N Y Acad Sci (1999) 0.90

Exogenous surfactant kinetics in infant respiratory distress syndrome: A novel method with stable isotopes. Am J Respir Crit Care Med (2000) 0.89

Site-directed mutagenesis of conserved cysteine residues within the beta subunit of Escherichia coli nitrate reductase. Physiological, biochemical, and EPR characterization of the mutated enzymes. Biochemistry (1993) 0.89

Enzymatic and physiological properties of the tungsten-substituted molybdenum TMAO reductase from Escherichia coli. Mol Microbiol (1999) 0.89

Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug? J Thromb Haemost (2006) 0.89

Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun (2003) 0.89

Oncocytic mucoepidermoid carcinoma of a submandibular gland: a case report and review of the literature. Int J Oral Maxillofac Surg (2007) 0.88

Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal. Int Clin Psychopharmacol (1996) 0.88

Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study. European Multicentre Cabergoline Dose-finding Study Group. Clin Endocrinol (Oxf) (1992) 0.88

Central neurocytoma: clinico-pathological study of 5 cases and review of the literature. Clin Neurol Neurosurg (1995) 0.88

Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype. Eur J Gastroenterol Hepatol (2001) 0.88

Circulating T lymphocytes in Hashimoto's disease: imbalance of subsets and presence of activated cells. Clin Immunol Immunopathol (1982) 0.88

Molybdenum cofactor properties and [Fe-S] cluster coordination in Escherichia coli nitrate reductase A: investigation by site-directed mutagenesis of the conserved his-50 residue in the NarG subunit. Biochemistry (1998) 0.88

Thyroid hormone stimulates the production of insulin-like growth factor I (IGF-I) by immature rat Sertoli cells. Mol Cell Endocrinol (1990) 0.88

Simultaneous measurement of the rates of appearance of palmitic and linoleic acid in critically ill infants. Pediatr Res (1997) 0.87

Hypopituitarism induced by traumatic brain injury in the transition phase. J Endocrinol Invest (2005) 0.87

Acrofacial dysostosis syndromes: a relevant prenatal dilemma. A case report and brief literature review. J Matern Fetal Neonatal Med (2007) 0.87